Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

291
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
291
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

476
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
476

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bereavement Care After Stillbirth in Uttar Pradesh: A Qualitative Analysis of the Present Situation, Challenges, and Solutions.

Journal of obstetrics and gynaecology of India·2026
Same author

Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Gastroenterology research·2026
Same author

Challenging Anticoagulation With Warfarin and Heparin Following Mechanical Mitral Valve Replacement in a Patient With Infective Endocarditis: A Case Report Highlighting Diagnostic Difficulties.

Clinical case reports·2026
Same author

Trauma-informed perinatal care for asylum-seeking and refugee women survivors of conflict-related and gender-based violence in the UK.

The British journal of psychiatry : the journal of mental science·2026
Same author

We need narrative approaches to children's mental health in conflict.

BMJ (Clinical research ed.)·2026
Same author

Overactive bladder among medical and nonmedical students: A comparative study of prevalence and impact on quality of life.

Medicine·2026

Related Experiment Video

Updated: Nov 5, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.4K

Biomarkers in Migraine.

Brian M Yan1, E M Gibson Depoy2, Ayesha Ahmad2

  • 1Sidney Kimmel Medical College, Thomas Jefferson University, USA.

Neurology India
|May 18, 2021
PubMed
Summary

Migraine biomarkers are being researched for diagnosis and treatment. While many diagnostic markers exist, calcitonin gene-related peptide (CGRP) and PACAP-38 show promise for targeted migraine therapies.

Keywords:
Biomarkercerebral spinal fluidmarkermigrainesalivaserum

More Related Videos

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
05:49

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

1.1K
Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
16:13

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro

Published on: June 13, 2011

20.2K

Related Experiment Videos

Last Updated: Nov 5, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.4K
Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
05:49

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

1.1K
Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
16:13

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro

Published on: June 13, 2011

20.2K

Area of Science:

  • Neurology
  • Biochemistry
  • Genetics

Background:

  • Migraine disability significantly impacts global economies.
  • Ongoing research seeks diagnostic and therapeutic biomarkers for migraine.
  • Biomarkers are crucial for advancing precision medicine in neurology.

Purpose of the Study:

  • To review current diagnostic and therapeutic migraine biomarkers.
  • To evaluate the role of these biomarkers in precision medicine.
  • To identify key biomarkers with clinical relevance.

Main Methods:

  • Comprehensive literature search of PubMed, Google Scholar, and clinicaltrials.gov.
  • Keywords included "migraine," "headache," "biomarkers," "serum," "cerebral spinal fluid," "inflammatory," and "neuroimaging."
  • Analysis of 88 relevant research papers.

Main Results:

  • Numerous biomarkers support migraine diagnosis.
  • Calcitonin gene-related peptide (CGRP) and PACAP-38 are key therapeutic biomarkers.
  • Genetic markers and associated biochemical alterations show potential.

Conclusions:

  • Several proposed biomarkers exist for migraine.
  • Further research is necessary to validate biomarkers for clinical use.
  • Biomarker research is essential for advancing migraine treatment.